HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yihan Li Selected Research

Yihan Li Research Topics

Disease

14Rheumatoid Arthritis
01/2022 - 07/2016
9Infections
01/2022 - 01/2013
6Neoplasms (Cancer)
02/2022 - 01/2013
4Pain (Aches)
12/2020 - 11/2019
3Herpes Zoster
01/2022 - 01/2018
2Osteoarthritis
12/2020 - 01/2020
2Hypersensitivity (Allergy)
11/2018 - 11/2018
2Psoriatic Arthritis
11/2018 - 11/2018
2Major Depressive Disorder (Major Depressive Disorders)
12/2015 - 02/2012
2Breast Neoplasms (Breast Cancer)
04/2014 - 04/2014
1Chronic Disease (Chronic Diseases)
01/2023
1Shock
11/2022
1Bone Resorption
10/2022
1Colorectal Neoplasms (Colorectal Cancer)
02/2022
1Arteriosclerosis
01/2022
1Venous Thromboembolism
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Disease Progression
12/2021
1Cognitive Dysfunction
12/2021
1Rolandic Epilepsy (Centrotemporal Epilepsy)
10/2021
1Ovarian Neoplasms (Ovarian Cancer)
10/2021
1Epilepsy (Aura)
01/2021
1Wounds and Injuries (Trauma)
11/2020
1Weight Loss (Weight Reduction)
11/2020
1Disease Resistance
09/2020
1Hyperglycemia
09/2020
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
07/2020
1Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2020
1Colic (Abdominal Cramps)
01/2020
1Intussusception
01/2020
1Amyloidosis
01/2020
1Absence Epilepsy (Childhood Absence Epilepsy)
01/2020
1Osteoporosis
03/2019
1Dehydration (Water Stress)
01/2019
1Hyperplasia
01/2019
1Experimental Arthritis
01/2019
1Arthritis (Polyarthritis)
01/2019

Drug/Important Bio-Agent (IBA)

8Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 01/2018
7upadacitinibIBA
01/2022 - 01/2018
5Adalimumab (Humira)FDA Link
01/2022 - 01/2018
3CollagenIBA
10/2022 - 04/2014
3Proteins (Proteins, Gene)FDA Link
02/2022 - 04/2014
3Interleukin-17 (Interleukin 17)IBA
11/2018 - 11/2018
2Janus Kinase InhibitorsIBA
01/2022 - 01/2021
2AntigensIBA
10/2021 - 01/2013
2Anticonvulsants (Antiepileptic Drugs)IBA
10/2021 - 01/2021
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2020 - 01/2020
2huatan tongluoIBA
01/2019 - 07/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2013
2Therapeutic UsesIBA
01/2019 - 07/2016
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2018 - 11/2018
2C-Reactive ProteinIBA
11/2018 - 01/2018
2ABT-122IBA
11/2018 - 11/2018
2Biological ProductsIBA
01/2018 - 01/2014
1NitritesIBA
11/2022
1WastewaterIBA
11/2022
1NitrogenIBA
11/2022
1Matrix Metalloproteinases (MMPs)IBA
10/2022
1CalnexinIBA
02/2022
1LDL CholesterolIBA
01/2022
1hydroxide ionIBA
01/2022
1Anti-Citrullinated Protein AntibodiesIBA
01/2022
1aducanumabIBA
12/2021
1donanemabIBA
12/2021
1lecanemabIBA
12/2021
1Small Interfering RNA (siRNA)IBA
10/2021
1Immune Sera (Antisera)IBA
05/2021
1Opioid Analgesics (Opioids)IBA
12/2020
1Nerve Growth Factor (NGF)IBA
12/2020
1AntibodiesIBA
12/2020
1Adenosine Triphosphate (ATP)IBA
11/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
09/2020
1S-methyl benzo(1,2,3)thiadiazole-7-carbothioate (acibenzolar-S-methyl)IBA
09/2020
1Mitogen-Activated Protein KinasesIBA
09/2020
1CytokinesIBA
09/2020
1Bortezomib (Velcade)FDA Link
07/2020
1Pharmaceutical PreparationsIBA
01/2020
1Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2020
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2020
1Tramadol (K315)FDA LinkGeneric
01/2020
1InterleukinsIBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
01/2020
1lutikizumabIBA
01/2020
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2020
1Creatine Kinase (Creatine Phosphokinase)IBA
11/2019
1GelatinIBA
03/2019
1Fibroins (Fibroin)IBA
03/2019
1EnzymesIBA
03/2019
1strontium ranelate (protelos)IBA
03/2019
1Charcoal (Charbon)IBA
01/2019
1Flame Retardants (Fire Retardants)IBA
01/2019
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2019
1TitaniumIBA
01/2019
1amsonic acid (DAS)IBA
11/2018

Therapy/Procedure

4Therapeutics
01/2023 - 11/2019
1Immunotherapy
12/2021
1Drug Therapy (Chemotherapy)
07/2020
1Hematopoietic Stem Cell Transplantation
07/2020
1Replantation
11/2019
1Aftercare (After-Treatment)
01/2019